This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Core Laboratories NV (CLB)

NYSE: Basic Materials

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 797.52M 1.09B 1.07B 981.08M
Cost of Sales 532.65M 665.27M 662.97M 621.82M
Gross Operating Profit 264.87M 419.95M 410.54M 359.26M
Selling, General, and Administrative Expenses 49.73M 45.66M 51.99M 43.19M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 215.14M 374.30M 358.55M 316.08M
Depreciation & Amortization 27.46M 26.70M 25.47M 22.92M
Interest Income 56.00K 403.00K 776.00K 319.00K
Other Income - Net -26.18M 1.87M 0.00 0.00
Special Income / Charges -493.00K -3.35M -438.00K 3.80M
Total Income Before Interest Expenses (EBIT) 161.07M 346.53M 333.42M 297.28M
Interest Expense 12.38M 10.60M 9.32M 8.82M
Pre-Tax Income 148.69M 335.93M 324.10M 288.46M
Income Taxes 33.76M 77.31M 80.91M 71.85M
Minority Interest 85.00K 1.14M 383.00K 541.00K
Net Income From Continuing Operations 114.93M 258.63M 243.19M 216.61M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 114.93M 258.63M 243.19M 216.61M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 114.85M 257.49M 242.81M 216.07M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
115.42M 261.97M 243.63M 212.81M
Preferred Dividends
Net Income Available To Common 114.93M 258.63M 243.19M 216.61M
Basic EPS from Continuing Ops. 2.69 5.80 5.31 4.58
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.69 5.80 5.31 4.58
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.69 5.80 5.31 4.58
Basic Normalized Net Income/Share 2.70 5.88 5.32 4.50
EPS fr Continuing Ops. 2.68 5.77 5.28 4.54
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.68 5.77 5.28 4.54
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.68 5.77 5.28 4.54
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.69 5.85 5.29 4.46
Dividends Paid per Share 2.20 2.00 1.28 1.12
CLB News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

CLB Core Laboratories NV

Chart of CLB

Analysts Ratings for CLB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 5 5 5
Moderate Buy 1 1 1 1
Hold 4 3 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CLB ANALYST REPORT

CLB Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs